polilactofate

1.	Bailey, Howard H: 1 article (11/2006)
2.	Fleming, Gini F: 1 article (11/2006)
3.	Markman, Maurie: 1 article (11/2006)
4.	Armstrong, Deborah K: 1 article (11/2006)
5.	Rosen, David Marc: 1 article (02/2004)
6.	DeWeese, Theodore L: 1 article (02/2004)
7.	O'Meally, Robert: 1 article (02/2004)
8.	Zabelinka, Yelena: 1 article (02/2004)
9.	Denmeade, Samuel R: 1 article (02/2004)
10.	Gady, Alyssa M: 1 article (02/2004)

Related Diseases

1.	Neoplasms (Cancer) 08/15/2003 - "Mantel-Cox statistics were used to assess the efficacy of Paclimer at extending survival of tumor-bearing animals compared with control implants" 02/15/2004 - "Addition of a single acute dose of radiation significantly enhanced the effect of 10% PACLIMER Microspheres (P < 0.05), had minimal effect on 40% PACLIMER Microspheres, and no enhancing effect on tumors treated with placebo microspheres" 02/15/2004 - "RESULTS: Forty percent PACLIMER Microspheres significantly reduced tumor growth in the LNCaP orthotopic model" 02/15/2004 - "METHODS: Orthotopic LNCaP tumors were injected with 40% PACLIMER Microspheres (40% loading; w:w) when tumors were 100-200 mm(3)" 02/15/2004 - "TSU-xenografts were injected with PACLIMER Microspheres (10% and 40% loaded; w:w) or placebo microspheres when the tumors were approximately 100 mm(3)" Get all the results and reference details, order at left...
2.	Glioma (Gliomas) 08/15/2003 - "CONCLUSIONS: Paclimer extends survival in a rodent model of glioma with minimal morbidity and optimal pharmacokinetics." 01/01/2006 - "To minimize toxicity and reach therapeutic concentrations in the CNS, paclitaxel was previously incorporated into biodegradable microspheres (Paclimer), and the efficacy of Paclimer was determined in a rat model of malignant glioma" Get all the results and reference details, order at left...
3.	Lung Neoplasms (Lung Cancer) 12/01/1999 - "Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice." Get all the results and reference details, order at left...
4.	Gliosarcoma 08/15/2003 - "In vivo studies of Paclimer were performed as intracranial implants in Fischer 344 rats in the presence or absence of 9L gliosarcoma" 08/15/2003 - "In vivo, Paclimer implants placed intracranially in rats released active drug for up to 30 days after implantation and doubled the median survival of rats bearing established 9L gliosarcomas (median survival of paclitaxel-treated animals = 35 days; median survival of control-treated animal = 16 days; P < 0.0001)" Get all the results and reference details, order at left...
5.	Ovarian Neoplasms (Ovarian Cancer) 11/01/2006 - "A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study." Get all the results and reference details, order at left...
7 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Paclitaxel (Taxol)
2.	polilactofate
2 Drugs and Important Bio-Agents and 5 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Microspheres (Microsphere)
2.	Heterologous Transplantation (Xenotransplantation)
2 Therapies and Procedures and 4 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>